State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, 430079, China.
Department of Chemistry, and The Hong Kong Branch of Chinese National Engineering Research Center for Tissue Restoration and Reconstruction, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, 999077, China.
Nat Commun. 2023 Sep 2;14(1):5355. doi: 10.1038/s41467-023-41121-z.
Immunogenic programmed cell death, such as pyroptosis and ferroptosis, efficiently induces an acute inflammatory response and boosts antitumor immunity. However, the exploration of dual-inducers, particularly nonmetallic inducers, capable of triggering both pyroptosis and ferroptosis remains limited. Here we show the construction of a covalent organic framework (COF-919) from planar and twisted AIEgen-based motifs as a dual-inducer of pyroptosis and ferroptosis for efficient antitumor immunity. Mechanistic studies reveal that COF-919 displays stronger near-infrared light absorption, lower band energy, and longer lifetime to favor the generation of reactive oxygen species (ROS) and photothermal conversion, triggering pyroptosis. Because of its good ROS production capability, it upregulates intracellular lipid peroxidation, leading to glutathione depletion, low expression of glutathione peroxidase 4, and induction of ferroptosis. Additionally, the induction of pyroptosis and ferroptosis by COF-919 effectively inhibits tumor metastasis and recurrence, resulting in over 90% tumor growth inhibition and cure rates exceeding 80%.
免疫原性程序性细胞死亡,如细胞焦亡和铁死亡,能够有效地诱导急性炎症反应并增强抗肿瘤免疫。然而,能够触发细胞焦亡和铁死亡的双重诱导剂,特别是非金属诱导剂的探索仍然有限。在这里,我们展示了一种由平面和扭曲的基于 AIEgen 的结构单元构建的共价有机框架(COF-919),作为一种能够有效诱导抗肿瘤免疫的细胞焦亡和铁死亡的双重诱导剂。机制研究表明,COF-919 具有更强的近红外光吸收、更低的能带能量和更长的寿命,有利于活性氧(ROS)的产生和光热转换,从而引发细胞焦亡。由于其良好的 ROS 产生能力,它上调了细胞内脂质过氧化,导致谷胱甘肽耗竭、谷胱甘肽过氧化物酶 4 表达降低以及铁死亡的诱导。此外,COF-919 诱导的细胞焦亡和铁死亡有效地抑制了肿瘤转移和复发,导致超过 90%的肿瘤生长抑制和超过 80%的治愈率。